CASIF — Stock activity · TradeandTellCASI
CASIF
$0.15+$0.00 (+1.40%)live
Held by
0
portfolios on TandT
Avg position size
—
of holders' portfolios
52-week range
$0.05 – $0.35
33% from low
Held by traders on TradeandTell
No one on the platform currently holds CASIF.
Super investors & insiders
Institutions holding (13F)
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded CASIF yet.
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Analyst estimates (consensus)
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|
| 2026 | $20M | +45.2% | $-1.41 | $-1.41–$-1.41 | — | 1 |
| 2027 | $89M | +356.7% | $-1.39 | $-1.39–$-1.39 | — | 1 |
| 2028 | $108M | +20.8% | $-1.37 | $-1.37–$-1.37 | — | 1 |
| 2029 | $11M | -89.7% | $-0.97 | $-0.97–$-0.97 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Earnings surprises
Beat consensus in 2 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|
| 2026-03-30 | $-0.36 | $-0.79 | -119.4% |
| 2025-11-14 | $-0.40 | $-0.67 | -67.5% |
| 2025-08-29 | $-0.47 | $-0.86 | -83.0% |
| 2025-05-16 | $-0.61 | $-0.69 | -13.1% |
| 2025-03-31 | $-0.60 | $-0.79 | -31.7% |
| 2024-11-15 | $-0.62 | $-0.55 | +11.3% |
| 2024-08-16 | $-0.63 | $-0.52 | +17.5% |
| 2024-05-14 | $-0.05 |
Peer comparison
| Symbol | Price | Today | Mkt cap | P/E |
|---|
| CASIFCASI Pharmaceuticals, Inc. | $0.15 | +13.85% | $3M | — |
| ALLRAllarity Therapeutics, Inc. | $1.37 | +0.74% | $22M | — |
| CINGCingulate Inc. | $5.09 | +2.00% | $69M | — |
| CLSDClearside Biomedical, Inc. | $0.41 | +0.00% | $2M | — |
| CRISCuris, Inc. | $1.80 | -3.74% |
| ENTOEntero Therapeutics, Inc. | $2.85 | -5.00% | $14M | — |
| KAPAKairos Pharma, Ltd. | $0.34 | -5.28% | $7M | — |
Source: Financial Modeling Prep · peers by sector/industry